Home>>Signaling Pathways>> Metabolism>> PDE>>MBCQ

MBCQ Sale

目录号 : GC16849

An inhibitor of PDE5

MBCQ Chemical Structure

Cas No.:150450-53-6

规格 价格 库存 购买数量
5mg
¥765.00
现货
10mg
¥1,350.00
现货
25mg
¥2,700.00
现货
50mg
¥4,500.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

产品文档

Quality Control & SDS

View current batch:

产品描述

MBCQ is a cGMP-specific phosphodiesterase PDE5 inhibitor.

The phosphodiesterase type 5 inhibitor (PDE5 inhibitor) is an agent used to inhibit the degradative action of cGMP-specific PDE5 on cyclic GMP in the smooth muscle cells lining the blood vessels supplying the corpus cavernosum of the penis. PDE5 drugs are used in the treatment of erectile dysfunction and were the first effective oral treatment for this condition. Sinve PDE5 is also present in the arterial wall smooth muscle within the lungs, PDE5 inhibitors have also been applied for the pulmonary hypertension treatment.

In vitro: In previous study, it was found that the addition of MBCQ to the blood vessle samples could lead to an 80 to 85% inhibition of PDE activity, indicating that most of the activity present in these blood vessels could be attributed to PDE5. [1].

In vivo: In animal rat study, tolerance was induced by continuous exposure to glyceryl trinitrate (GTN) for 48 h. Results showed that MBCQ could significantly decrease the EC(50) values for GTN-induced relaxation in both tolerant and nontolerant tissues, but with the greatest relative shift showing in tolerant veins. Moreover, MBCQ could also increase the vasodilator potency of a nitric oxide donor (1,1-diethyl-2-hydroxy-2-nitrosohydrazine). A significant increase in cGMP PDE activity was found in tolerant femoral vein, whereas PDE activity was unchanged in femoral artery [1].

Clinical trial: Up to now, MBCQ is still in the preclinical development stage.

Reference:
[1] MacPherson JD, Gillespie TD, Dunkerley HA, Maurice DH, Bennett BM.  Inhibition of phosphodiesterase 5 selectively reverses nitrate tolerance in the venous circulation. J Pharmacol Exp Ther. 2006 Apr;317(1):188-95.

Chemical Properties

Cas No. 150450-53-6 SDF
化学名 N-(1,3-benzodioxol-5-ylmethyl)-6-chloro-4-quinazolinamine
Canonical SMILES ClC1=CC2=C(C=C1)N=CN=C2NCC3=CC(OCO4)=C4C=C3
分子式 C16H12ClN3O2 分子量 313.7
溶解度 DMSO: 5 mg/ml 储存条件 Store at -20°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 3.1878 mL 15.9388 mL 31.8776 mL
5 mM 0.6376 mL 3.1878 mL 6.3755 mL
10 mM 0.3188 mL 1.5939 mL 3.1878 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置